NCT03210337 - A Phase2 of A-101 Topical Solution in Subjects With Common Warts | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

March 16, 2018

Study Completion Date

March 16, 2018

Conditions

Common Wart

Interventions

DRUG

A-101 Topical Solution

DRUG

A-101 Vehicle Solution

Trial Locations (17)

10155

Aclaris Investigational Site, New York

19008

Aclaris Investigational Site, Broomall

19034

Aclaris Investigational Site, Fort Washington

29644

Aclaris Investigational Site, Fountain Inn

30263

Aclaris Investigational Site, Newnan

33137

Aclaris Investigational Site, Miami

46168

Aclaris Investigational Site, Plainfield

46256

Aclaris Investigational Site, Indianapolis

48088

Aclaris Investigational Site, Warren

55432

Aclaris Investigational Site, Fridley

60005

Aclaris Investigational Site, Arlington Heights

72758

Aclaris Investigational Site, Rogers

78213

Aclaris Investigational Site, San Antonio

78759

Aclaris Investigational Site, Austin

85225

Aclaris Investigational Site, Scottsdale

92103

Aclaris Investigational Site, San Diego

92123

Aclaris Investigational Site, San Diego